Post Profile






First feasibility study of the ESMO-MCBS scale in rare tumor entities

(European Society for Medical Oncology) The results of the first study analysing the application of the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) in a real-life context for rare tumour entities, were announced today at the ESMO 2016 Congress in Copenhagen.
read more

share

Related Posts


More research urged to compare and validate genomic tests for patients with early breast cancer

Health : Medical News Today

The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy. The new trial results[1],...

Results of first study assessing clinical impact of ESMO-MCBS

Academics / General Science : ScienceDaily: Science Society

Details of the first study by one of Europe's largest cancer centers assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale in a real-life context are now available to the public.

Biothera To Present Research Results At European Society For Medical Oncology World Gastrointestinal Congress

Health : Medical News Today

Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in B...

Results of first study assessing clinical impact of ESMO-MCBS

Academics / General Science : Science Codex

LUGANO, 7 July 2016 - Details of the first study by one of Europe's largest cancer centres, the Medical University of Vienna (MUV), assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale (MCBS)...

Scale to stratify magnitude of clinical benefit of anticancer medicines

Academics / General Science : ScienceDaily: Science Society

ESMO, the European Society for Medical Oncology, has announced the publication of the ESMO Magnitude of Clinical Benefit Scale, a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their pa...

Comments


Copyright © 2016 Regator, LLC